The global stem cell banking market is expected to reach USD 3.96billion by 2021 from USD 1.58 billion in 2016, at a CAGR of 20.2% from 2016 to 2021.The storage services segment is expected to contribute the maximumsh are to the overall market in 2016.Advancements in cord blood preservation and research in the field of stem cells for use as therapeutics are major factors fueling the growth of this market.
The global Stem Cell Banking Market is classified on the basis of type into cord blood and cord blood & cord tissue. On the basis of services, the market is segmented into collection & transportation, processing, analysis, and storage. The major applications of stem cell banking include cerebral palsy, leukemia, thalassemia, anemia, autism, diabetes, and others. Among these applications, stem cells are mainly used for the treatment of cerebral palsy.
Complete report on Stem Cell Banking Market spread across 119 pages, profiling 11 companies and supported with 62 tables and 40 figures is now available at http://www.rnrmarketresearch.com/stem-cell-banking-market-by-bank-type-cord-blood-and-cord-tissue-service-collection-transportation-analysis-processing-and-storage-application-cerebral-palsy-leukemia-thalassemia-anemia-autism-diab-st-to-2021-market-report.html
The storage services segment is estimated to command the largest share in 2016 and the forecast period. North America is the major market for this segment. The high share of the storage services segment can be attributed to the high cost of the equipment required for the storage of cord blood and cord tissue, in turn increasing the per-year cost of maintenance of the sample units.
“Processing services to contribute largest share in the stem cell biobanking market”
The processing services segment is estimated dominate the market, by service type, in 2016 and the forecast period. North America is the major market for this segment. The large share of the storage services segment can be attributed to the high cost of the technology and equipment required for the processing of cord blood and cord tissue, in turn increasing the per-year cost of maintenance of the sample units.
Earlier, semi-automated centrifuges, such as AXP Auto Xpress from Thermo genesis and Compomat from Fresenius Kabi (India) were used to separate blood components. However, companies are now focusing on updating technology to deliver high-quality products. For instance, Cordlife (Singapore) used Sepax, a fully automated closed system, in 2013, which has now become an industry standard followed by companies globally. In all the cases, the buffy coat is stored in single compartment cryobags.
Now Get Discount on This Report at http://www.rnrmarketresearch.com/contacts/discount?rname=636026 ( Report PIricer for USD 5650)
“North America is the largest contributor to the global stem cell banking market, while Asia-Pacific is the fastest-growing market segment”
The U.S. is the largest segment of the North American market. This market is witnessing a shift in the preference from public to private banks. Parents are increasingly looking to storing their children’s cord blood and tissue in private banks because of the possibility that samples in public banks may be given to other people for transplants or to research organizations. In the Asia-Pacific, market growth will be driven by the rising number of newborns and the low prices of storage services.
The stem cell biobanking market includes over 500 companies and banks across the globe; this also serves to aid market growth. These players include StemCyte (U.S.), Cryo-Cell International (U.S.), ViaCord (U.S.), Cord Blood Registry (U.S.), Smart Cells (U.K.), Cryo-Save (Netherlands), Cryoviva (India), LifeCell (India), Cordlife (Singapore), Cordvida (Brazil), and China Cord Blood Corporation (China).
Scope of the Report:
This report categorizes the stem cell biobanking market on the basis of service type, application, and region.
Market Segmentation, by Type: Based on type, the stem cell biobanking market has been segmented into: Cord Blood ,Cord Blood & Cord Tissue
Market Segmentation, by Service Type: Based on service type, the stem cell biobanking market has been segmented into: Collection and Transportation , Processing, Analysis and Storage
Market Segmentation, by Application: Based on application, the stem cell biobanking market has been segmented into: Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes, Others
Market Segmentation, by Region: The regional analysis covers: North America, Europe, Asia, Rest of the World (RoW)
Gist of Table of Contents
Market Segmentation, Stem Cell Banking, By Bank Type, Stem Cell Banking, By Service, Stem Cell Banking, By Application, Market Dynamics, Drivers, Easy Extraction Methods, Rising Number of Newborns, Growth in Gdp, Disposable Income, and Increased Awareness of Stem Cell Therapeutics, Potential of Stem Cells in Disease Treatment, Restraints, High Competition in the Stem Cell Banking Market, High Operating Cost, Lack of Acceptance, Changes in Legal Regulations, Opportunities, Rising Awareness About Potential Use of Cord Tissue, Collaborations Among Cord Blood Banks, The Automation of Procedures, Challenges, Entry Barriers in the Market
Stem Cell Banking Market, By Bank Type Introduction, Cord Blood, Cord Tissue
Stem Cell Banking Market, By Service, Introduction, Collection & Transportation, Processing, Analysis, Storage
Stem Cell Banking Market, By Application Introduction, Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism, Others
Stem Cell Banking Market, By Region Introduction, North America, North America, By Country, North America, By Type, North America, By Service, North America, By Application, Europe, Europe, By Country, Europe, By Type, Europe, By Service, Europe, By Application, Asia-Pacific, Asia-Pacific, By Country, Asia-Pacific, By Type, Asia-Pacific, By Service, Asia-Pacific, By Application, Rest of The World (RoW), Rest of the World, By Type, Rest of the World, By Service, Rest of the World, By Application
Competitive Landscape Company Share Analysis, New Service/Product Launches, Mergers & Acquisitions, Regulatory Approvals, Partnerships, Joint Venture, Agreements, Collaborations, Technological Update, Patent,Geographical Expansion, Others